UK markets close in 7 hours 42 minutes
  • FTSE 100

    7,300.49
    +68.21 (+0.94%)
     
  • FTSE 250

    23,093.82
    +212.49 (+0.93%)
     
  • AIM

    1,187.56
    +7.53 (+0.64%)
     
  • GBP/EUR

    1.1765
    +0.0015 (+0.13%)
     
  • GBP/USD

    1.3280
    +0.0020 (+0.15%)
     
  • BTC-GBP

    38,601.73
    +2,119.66 (+5.81%)
     
  • CMC Crypto 200

    1,328.11
    +67.95 (+5.39%)
     
  • S&P 500

    4,591.67
    +53.24 (+1.17%)
     
  • DOW

    35,227.03
    +646.95 (+1.87%)
     
  • CRUDE OIL

    70.77
    +1.28 (+1.84%)
     
  • GOLD FUTURES

    1,783.70
    +4.20 (+0.24%)
     
  • NIKKEI 225

    28,455.60
    +528.23 (+1.89%)
     
  • HANG SENG

    23,983.66
    +634.28 (+2.72%)
     
  • DAX

    15,608.57
    +227.78 (+1.48%)
     
  • CAC 40

    6,975.40
    +109.62 (+1.60%)
     

NuCana Soars as FDA Fast Tracks Potential Drug for Biliary Tract Cancer

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

By Dhirendra Tripathi

Investing.com – NuCana stock (NASDAQ:NCNA) climbed 22% in Wednesday’s premarket trading as the Food and Drug Administration fast-tracked the company’s experimental drug for treatment of biliary tract cancer.

The drug, acelarin, is currently being evaluated in a phase-III study for the first-line treatment of patients.

The FDA's announcement means that company and regulator will now stay in constant touch throughout the entire drug development and review process. This will ensure quick resolution of questions and issues to eventually result in earlier drug approval and access by patients, assuming the drug meets FDA norms.

A drug is fast tracked when no previous treatment exists or when the proposed solution has proven to be better than the available therapy.

The biliary tract comprises the gallbladder and interconnecting ducts responsible for the transport of bile from the liver to the gallbladder and small intestine. Approximately 178,000 new cases of biliary tract cancer are diagnosed each year worldwide, with more than 18,000 of those diagnoses in the U.S.

Related Articles

NuCana Soars as FDA Fast Tracks Potential Drug for Biliary Tract Cancer

China Evergrande to sell $1.5 billion stake in Shengjing Bank to state firm

Angelo Gordon hires Blackstone's Soussa as chief strategy officer

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting